INTRODUCTION: Cervical cancer (CC), compared with other gynecological cancers, has critical implications for women's sexual lives. For most Asian people, the issue of sexual dysfunction (SD) is treated as a taboo especially in a conservative culture. As a result, little is known about the prevalence of SD among CC patients. AIMS: The purpose of this study was to investigate the prevalence of SD and associated factors among CC patients. METHODS: We used a cross-sectional correlation design with the purposive sampling to recruit 105 CC patients from a hospital in Northern Taiwan. A structured questionnaire was used in this study to collect demographic data, disease characteristics, and information provided by the Chinese version of the Female Sexual Function Index scale. Data were analyzed by descriptive statistics, independent t-test, chi-square test, and multiple logistic regression. MAIN OUTCOME MEASURE: The prevalence of SD and the main predictors for SD were determined. RESULTS: The crude prevalence and age-standardized prevalence of SD were 66.67% and 55%, respectively. CC patients with a lower level of education (≤9th grade) (adjusted odds ratio [AOR]: 3.14; 95% confidence interval [CI]: 1.51-10.37), who were older (AOR: 1.16; 95% CI: 1.07-1.25), who had received no sexual-counseling services prior to therapy or later (AOR: 4.98; 95% CI: 2.31-9.71), or were stage II or above (AOR: 4.34; 95% CI: 1.65-19.09) showed a significantly higher risk of SD compared with those without these conditions. CONCLUSIONS: Our findings are beneficial to health-care providers by identifying the prevalence of SD and by pinpointing those groups with a higher predisposition of having SD, which will allow the provision of appropriate rehabilitation.
INTRODUCTION:Cervical cancer (CC), compared with other gynecological cancers, has critical implications for women's sexual lives. For most Asian people, the issue of sexual dysfunction (SD) is treated as a taboo especially in a conservative culture. As a result, little is known about the prevalence of SD among CC patients. AIMS: The purpose of this study was to investigate the prevalence of SD and associated factors among CC patients. METHODS: We used a cross-sectional correlation design with the purposive sampling to recruit 105 CC patients from a hospital in Northern Taiwan. A structured questionnaire was used in this study to collect demographic data, disease characteristics, and information provided by the Chinese version of the Female Sexual Function Index scale. Data were analyzed by descriptive statistics, independent t-test, chi-square test, and multiple logistic regression. MAIN OUTCOME MEASURE: The prevalence of SD and the main predictors for SD were determined. RESULTS: The crude prevalence and age-standardized prevalence of SD were 66.67% and 55%, respectively. CC patients with a lower level of education (≤9th grade) (adjusted odds ratio [AOR]: 3.14; 95% confidence interval [CI]: 1.51-10.37), who were older (AOR: 1.16; 95% CI: 1.07-1.25), who had received no sexual-counseling services prior to therapy or later (AOR: 4.98; 95% CI: 2.31-9.71), or were stage II or above (AOR: 4.34; 95% CI: 1.65-19.09) showed a significantly higher risk of SD compared with those without these conditions. CONCLUSIONS: Our findings are beneficial to health-care providers by identifying the prevalence of SD and by pinpointing those groups with a higher predisposition of having SD, which will allow the provision of appropriate rehabilitation.
Authors: Diana D Jeffery; Lisa Barbera; Barbara L Andersen; Amy K Siston; Anuja Jhingran; Shirley R Baron; Jennifer Barsky Reese; Deborah J Coady; Jeanne Carter; Kathryn E Flynn Journal: J Psychosoc Oncol Date: 2015
Authors: Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito Journal: Endocrine Date: 2015-12-07 Impact factor: 3.633
Authors: Yumi Lee; Myong Cheol Lim; Se Ik Kim; Jungnam Joo; Dong Ock Lee; Sang-Yoon Park Journal: Cancer Res Treat Date: 2016-02-12 Impact factor: 4.679
Authors: Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin Journal: Cancer Nurs Date: 2021 Sep-Oct 01 Impact factor: 2.592